In a year when the scientific world turned once again toward the quiet machinery of the mind, the Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics. Their work began with humble green algae in a pond and grew into a way of taking hold of living brain cells with light itself. For a long time neuroscience could only watch the brain at work; now it can reach in and nudge specific parts of it, and that shift marks a new chapter in the long human effort to understand how thought, memory and movement arise.
Light as a Switch: How Optogenetics Earned the 2026 Nobel Prize in Physiology or Medicine
Moving the field from observing the brain to actively controlling it
Mark
Start with the basics. What did the three of them actually do?
Mimi
Hegemann and Nagel found channelrhodopsins in green pond algae, proteins that open like doors when blue light hits them. Deisseroth put the genes for those proteins into specific nerve cells in animals.
Mark
So the cell becomes light-sensitive.
Mimi
Yes. Shine a fiber-optic light on the tissue and the neuron fires. Other engineered proteins turn neurons off with a different color, like yellow.
Mark
Why does the Nobel Assembly call it a revolution?
Mimi
Because it moved neuroscience from watching the brain to controlling it. Drugs and electrical shocks hit every nearby cell. This hits one type of neuron and leaves its neighbors alone.
Luke
Let me slow down on the disease claims. The article says it provides insights into Parkinson's, schizophrenia, depression, addiction and Alzheimer's. That's insight, not treatment.
Mimi
Fair. The mapping work was done in living animals, and the piece says it is helping explain these conditions.
Luke
And the vision result? It says partial restoration in retinitis pigmentosa.
Mimi
Right, partial, in clinical human trials. The article gives no patient numbers or trial details.
Mark
So what's solid?
Luke
The prize, the three names, the mechanism, and the contrast with older tools. How far the human applications go is not something this piece can tell us.
Il Polso
- A single flash of light can now open or silence one type of brain cell in a living animal within milliseconds.
- Older tools like drugs and electrical shocks spread across neighboring cells, blurring what researchers were trying to learn.
- Scientists are using this precision to trace the circuits behind memory, movement and behavior, and to probe Parkinson's, depression, addiction and Alzheimer's.
- In early human trials, patients with inherited blindness from retinitis pigmentosa have regained partial vision, a first step from lab models into people.
- The open question is whether brain disorders will follow vision's path from animal mapping to real treatments for patients.
In a year when the scientific world turned once again toward the quiet machinery of the mind, the Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics. Their work began with humble green algae in a pond and grew into a way of taking hold of living brain cells with light itself. For a long time neuroscience could only watch the brain at work; now it can reach in and nudge specific parts of it, and that shift marks a new chapter in the long human effort to understand how thought, memory and movement arise.
The 2026 Nobel Prize in Physiology or Medicine has gone to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics, a method that uses pulses of light as a remote control for brain cells, switching them on or off with millisecond precision.
The story begins in a pond. Hegemann and Nagel discovered that certain single-celled green algae carry light-sensitive proteins called channelrhodopsins, tiny gated doors in the cell membrane that open when light of a particular color strikes them, letting electrical current flow.
Deisseroth made the leap that turned this curiosity into a tool. He inserted the genetic code for these proteins into specific nerve cells in animals, so that a fiber-optic light could open or silence exactly those neurons. The Nobel Assembly at Karolinska Institutet recognized that this changed neuroscience from a field that could only observe the brain into one that could act on it.
Older methods, drugs and electrical shocks, were blunt instruments that affected every nearby cell. Optogenetics lets researchers isolate one neuron type and leave its neighbors alone, which has helped map circuits behind memory, movement and behavior, and illuminate disorders such as Parkinson's, schizophrenia, depression, addiction and Alzheimer's.
The work has also reached people. In clinical trials, the algal proteins have partially restored vision in patients with genetic blindness from retinitis pigmentosa. The result is partial, but it is a gain in patients rather than only in laboratory models.
The next test is whether research on brain disorders follows the same path, moving from animal circuit maps toward trials in the conditions the prize citation names.
The 2026 Nobel Prize in Physiology or Medicine has gone to three scientists, Karl Deisseroth, Peter Hegemann and Georg Nagel, for optogenetics: a technique that lets researchers use pulses of light as a remote control, switching specific brain cells on or off with millisecond precision.
The story starts in a pond. Hegemann and Nagel found that certain single-celled green algae carry special proteins called channelrhodopsins. These proteins work as light-gated ion channels, tiny doors in the cell membrane that swing open when particular colors of light, blue for example, strike them. When the door opens, electrical current flows.
Deisseroth supplied the next step. He took the genetic code for these light-sensitive proteins and inserted it into the DNA of specific nerve cells in animals. Once a targeted neuron produces the protein, a researcher can direct a thin fiber-optic light onto the brain tissue. A flash forces the channel open and the neuron fires a signal. Other engineered proteins do the opposite, silencing neurons when hit by a different color, such as yellow.
The Nobel Assembly at Karolinska Institutet honored the work because it changed what neuroscience could do. The field had largely been able to observe the brain. Optogenetics let it act on the brain directly.
The contrast with earlier methods is sharp. Before this, scientists stimulating the brain relied on drugs or electrical shocks. Both are messy tools that activate surrounding cells without discrimination. Optogenetics lets researchers single out one exact type of neuron and leave its neighbors untouched.
That selectivity has let researchers map how neural circuits shape memories, feelings, movement and complex behaviors in living animals. It is also giving insight into what goes wrong in neurological and psychiatric conditions, including Parkinson's disease, schizophrenia, depression, addiction and Alzheimer's.
The technique has also left the animal laboratory. In clinical human trials, researchers have used the algal proteins to partially restore vision in people with genetic blindness caused by retinitis pigmentosa. The restoration is partial, but it is a result in patients rather than in models.
What to watch next is whether the work on brain disorders follows the path vision has: from mapping circuits in animals toward trials in people with the conditions the prize citation names.
Citazioni salienti
The Nobel Assembly at Karolinska Institutet honored optogenetics for moving neuroscience from observing the brain to actively controlling it.— Paraphrase of the Nobel Assembly's rationale, as reported by News18
Vuoi la storia completa?
Leggi l'originale su News18 ↗
General News